本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Recursion Pharmaceuticals, Inc.

5.84
+0.11001.92%
盘后5.81-0.0300-0.51%19:59 EDT
成交量:1,383.00万
成交额:8,082.74万
市值:23.49亿
市盈率:-3.45
高:6.07
开:5.78
低:5.68
收:5.73
数据加载中...
2024/10/18

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/02

重要事件披露

Form 8-K - Current report
2024/10/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/03

重要事件披露

Form 8-K - Current report
2024/08/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/28

重要事件披露

Form 8-K - Current report
2024/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities